HOME > ARCHIVE
ARCHIVE
- REGULATORY NEWS IN BRIEF
May 26, 2003
- Annual Business Results
May 26, 2003
- 50th Anniversary of DNA Discovery Celebrated
May 26, 2003
- Shoda Appointed President of Sankyo
May 26, 2003
- Annual Business Results
May 26, 2003
- RESEARCH &DEVELOPMENT NEWS IN BRIEF
May 26, 2003
- Meet the Leaders (19)
May 19, 2003
- Nearly All Regulatory Reform Items for FY2002 Implemented: Reform Council
May 19, 2003
- Eisai Initiates Post-Aricept Project
May 19, 2003
- Iressa Safety Problems Discussed
May 19, 2003
- Merger of Marketing Systems Going Well: Taisho Toyama
May 19, 2003
- SARS ISSUES
May 19, 2003
- Sankyo Introduces SAP AG's SAP R/3 Integrated Info System
May 19, 2003
- Council Approves 3-year Plan to Stimulate Clinical Trials
May 19, 2003
- MPC to Create Marketing Subsidiary in Germany
May 19, 2003
- Health Promotion Law to Help Optimize Medical Spending: HSB Head
May 19, 2003
- Ethical Drug Sales Rose 3.7% in FY2002: CR&C Report
May 19, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
May 19, 2003
- BUSINESS NEWS IN BRIEF
May 19, 2003
- Yamanouchi's YM905 Effective for Pollakiuria: AUA Meeting
May 19, 2003
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
